67Indexed trials
mesh condition
Migraine Disorders
Intelligence
Migraine Disorders intelligence: 67 indexed trials, 8 recruiting studies, 53 sponsors across 42 countries.
8Recruiting
53Sponsors
42Countries
Leading sponsors
AbbVie54 recruiting
Pfizer50 recruiting
Danish Headache Center30 recruiting
Eli Lilly and Company30 recruiting
Allergan20 recruiting
H. Lundbeck A/S20 recruiting
Azienda Sanitaria Locale di Alessandria10 recruiting
Amgen10 recruiting
Ain Shams University10 recruiting
Centre Hospitalier Universitaire de Nice11 recruiting
Centro Cardiologico Monzino10 recruiting
Centre Hospitalier Universitaire de Besancon10 recruiting
Geographic activity
United States32trials
France7trials
Germany7trials
Italy6trials
Denmark6trials
Spain6trials
United Kingdom6trials
Netherlands5trials
Belgium5trials
Canada4trials
Japan4trials
Czechia4trials
Leading interventions
Atogepant3trials
Galcanezumab2trials
Saline2trials
Zavegepant2trials
Levcromakalim2trials
Transcranial direct current stimulation2trials
Anisodine Hydrobromide placebo1trials
Acupuncture1trials
CEFALY Active1trials
CBT Individual Psychotherapy1trials
CEFALY Placebo1trials
Anisodine Hydrobromide1trials
Methodology note
This entity is derived from structured ClinicalTrials.gov conditions and/or MeSH normalization. Counts reflect the current NeuroRisk indexed corpus and are not guaranteed exhaustive global totals.